Endoscopy 2014; 46(08): 656-661
DOI: 10.1055/s-0034-1365720
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Long-term outcomes after endoscopic ultrasonography-guided gallbladder drainage for acute cholecystitis

Authors

  • Jun-Ho Choi

    1   Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea
  • Sang Soo Lee

    2   Division of Gastroenterology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
  • Joon Hyuk Choi

    2   Division of Gastroenterology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
  • Do Hyun Park

    2   Division of Gastroenterology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
  • Dong-Wan Seo

    2   Division of Gastroenterology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
  • Sung Koo Lee

    2   Division of Gastroenterology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
  • Myung-Hwan Kim

    2   Division of Gastroenterology, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea
Weitere Informationen

Publikationsverlauf

submitted 17. November 2013

accepted after revision 24. März 2014

Publikationsdatum:
30. Juni 2014 (online)

Preview

Background and study aim: Endoscopic ultrasonography-guided transmural gallbladder drainage (EUS-GBD) has been proposed for the management of acute cholecystitis in high risk patients; however, little is known about the long-term outcomes of this treatment. The aim of this study was to evaluate the procedural and long-term outcomes of EUS-GBD with self-expandable metallic stent (SEMS).

Patients and methods: Data for this retrospective study were obtained from a prospectively collected EUS database. Patients with acute cholecystitis who were deemed unsuitable for cholecystectomy were included. Study outcomes were technical and clinical success, adverse events, and stent patency.

Results: EUS-GBD was technically and clinically successful in 62/63 patients (98.4 %; 95 % confidence interval [CI] 94.9 % – 100 %). Procedural adverse events included duodenal perforation (n = 1, 1.6 %) and self-limiting pneumoperitoneum (n = 2, 3.2 %), all of which resolved with conservative treatment. Long-term outcomes of EUS-GBD were evaluated in 56 patients who were followed for a median of 275 days (range 40 – 1185 days). Late adverse events developed in four patients (7.1 %; 95 %CI 5.7 % – 8.4 %), including asymptomatic distal stent migration (n = 2), and acute cholecystitis due to stent occlusion (n = 2). Two patients with occluded stent were successfully treated endoscopically (reintervention rate of 3.6 %). A total of 54 patients (96.4 %) had no recurrence of acute cholecystitis during follow-up. Median stent patency time was 190 days overall (range 15 – 1185 days) and 458 days (range 151 – 1185 days) for the 28 patients who were alive at the study end. The cumulative stent patency rate was 86 % at 3 years.

Conclusions: EUS-GBD with an SEMS for acute cholecystitis showed excellent long-term outcomes and may be a definitive treatment in patients who are unsuitable for cholecystectomy because of advanced malignancy or high surgical risk.